Journal of Research & Innovation in Anesthesia

Register      Login

VOLUME 1 , ISSUE 2 ( July-December, 2016 ) > List of Articles

RESEARCH ARTICLE

Comparison of Neuromuscular Blockade with Rocuronium in Young and Elderly Patients with or without Renal Failure

L Pradeep

Citation Information : Pradeep L. Comparison of Neuromuscular Blockade with Rocuronium in Young and Elderly Patients with or without Renal Failure. Res Inno in Anesth 2016; 1 (2):45-51.

DOI: 10.5005/jp-journals-10049-0012

License: CC BY-SA 4.0

Published Online: 01-12-2016

Copyright Statement:  Copyright © 2016; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract


PDF Share
  1. Rocuronium potency and recovery characteristics during steady-state desflurane, sevoflurane, isoflurane or propofol anaesthesia. Br J Anaesth 2000 Jan;84(1):43-47.
  2. Rocuronium pharmacokinetic-pharmacodynamic relationship under stable propofol or isoflurane anesthesia. Can J Anaesth 2002 Apr;49(4):353-360.
  3. Dose-response and time-course of the effect of rocuronium bromide during sevoflurane anaesthesia. Anaesthesia 1998 Jan;53(1):25-30.
  4. Newer neuromuscular blocking agents: how do they compare with established agents? Drugs 2001;61(7):919-942.
  5. Pharmacokinetics and pharmacodynamics of rocuronium (Org 9426) in elderly surgical patients. Anesth Analg 1993 Dec;77(6):1193-1197.
  6. Pharmacokinetics, pharmacodynamics, and dose-response relationships of pancuronium in control and elderly subjects. Anesthesiology 1982 Jan;56(1):36-40.
  7. Comparison of duration of neuromuscular blocking effect of atracurium and vecuronium in young and elderly patients. Br J Anesth 1995 Jun;74(6):709-711.
  8. Pharmacodynamic behaviour of rocuronium in the elderly. Can J Anaesth 1993 Feb;40(2):127-132.
  9. Comparison of the variability of the onset and recovery from neuromuscular blockade with cisatracurium versus rocuronium in elderly patients under total intravenous anesthesia. Braz J Med Biol Res 2012 Jul;45(7):676-680.
  10. Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. Curr Med Chem 2010;17(6):571-584.
  11. The effects of age on maintenance of intense neuromuscular block with rocuronium. Acta Anaesthesiol Scand 2012 Feb;56(2):236-239.
  12. The neuromuscular effects of 0.6 mg kg(-1) rocuronium in elderly and young adults with or without renal failure. Eur J Anaesthesiol 2008 Nov;25(11):940-946.
  13. Characteristics of neuromuscular block after administration of rocuronium bromide in patients with end-stage renal failure. Srp Arh Celok Lek 2011 Nov-Dec;139(11-12):765-771.
  14. Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study. Br J Anaesth 2010 Jan;104(1):31-39.
  15. Pharmacodynamics of rocuronium 0.3 mg kg(-1) in adult patients with and without renal failure. Eur J Anaesthesiol 2005 Dec;22(12):929-932.
  16. Pharmacokinetics and dosage adjustment in patients with renal dysfunction. Eur J Clin Pharmacol 2009 Aug;65(8):757-773.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.